PAM
IMRX icon

PVG Asset Management’s Immuneering IMRX Stock Holding History

PVG Asset Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Sell
146,451
-210
-0.1% -$1.06K 0.42% 62
2026
Q1 		$615K Buy
+146,661
New +$752K 0.36% 65

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

PVG Asset Management's IMRX Position: Q2 2026 in Review

PVG Asset Management reduced its Immuneering (IMRX) stake by 0.14% in Q2 2026, selling an estimated $1.06K and leaving 146,451 shares worth $731K. The position accounts for 0.42% of the portfolio, ranked #62.

PVG Asset Management first reported a position in IMRX in Q1 2026 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • PVG Asset Management held 146,451 shares of Immuneering worth $731K as of Q2 2026.
  • PVG Asset Management sold 210 Immuneering shares in Q2 2026, an estimated $1.06K.
  • Immuneering made up 0.42% of PVG Asset Management's portfolio in Q2 2026, its #62 holding.
  • PVG Asset Management first reported a position in Immuneering in Q1 2026 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on PVG Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.